-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-237-fullreport.pdf
October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; ages 29 days-1 year.
q.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-237-fullreport.pdf
October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; ages 29 days-1 year.
q.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-237-fullreport.pdf
October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; ages 29 days-1 year.
q.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-237-fullreport.pdf
October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; ages 29 days-1 year.
q.
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-237-fullreport.pdf
October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; ages 29 days-1 year.
q.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-237-fullreport.pdf
October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; ages 29 days-1 year.
q.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-237-fullreport.pdf
October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; ages 29 days-1 year.
q.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/racial-disparities-health-healthcare-protocol.pdf
January 06, 2022 - from the American
Academy of Pediatrics clinical practice
guideline for urinary tract infection in infants
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/racial-disparities-health-healthcare-protocol.pdf
January 06, 2022 - from the American
Academy of Pediatrics clinical practice
guideline for urinary tract infection in infants
-
effectivehealthcare-admin.ahrq.gov/products/racial-disparities-health-healthcare/protocol
March 01, 2023 - from the American Academy of Pediatrics clinical practice guideline for urinary tract infection in infants
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-237-fullreport.pdf
October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; ages 29 days-1 year.
q.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
effectivehealthcare.ahrq.gov/health-topics/meningococcal-infections